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TO THE EDITOR 
Ex-situ normothermic machine perfusion (NMP) of donor livers is an emerging innovation in 
liver transplantation that has made its transition to clinical trials. NMP is applied in an effort 
to overcome ischemia-reperfusion injury associated with static cold storage, to improve the 
quality of sub-optimally functioning donor organs and to permit viability testing of potentially 
transplantable livers. The in-vivo physiological conditions maintained during ex-situ NMP 
necessitate the need for a perfusion fluid that mimics the composition of whole blood. To 
date, perfusion fluids used in NMP studies are composed of either plasma-based solutions 
or plasma-free solutions consisting of colloids such as Gelofusine1. The latter avoids the use 
of human plasma which is scarce, costly and logistically challenging. 
During ex-situ NMP, in-vivo graft reperfusion is mimicked and normal metabolic and 
synthetic functions are restored. It was previously demonstrated that the international 
normalized ratio (INR) of a plasma-free perfusion solution decreased over time during 8 
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proteins during NMP. In this study however, the levels of procoagulant proteins produced 
were not quantified and the INR values reported are likely an underestimation as the 
perfusion fluid contained substantial amounts of heparin, which is known to interfere with 
INR measurements. To date, duration of NMP of human donor livers in published data 
ranges from 3.5 to 24 hours. Bral et al. have even successfully transplanted a donor liver 
after 22.5 hours of NMP3. Based on published data, it is likely that physiological amounts of 
hemostatic proteins are produced during prolonged periods of NMP. Therefore, the objective 
of this study was to quantify the levels of individual hemostatic proteins during NMP of donor 
livers with a plasma-free perfusion solution. 
Six human donor livers declined for transplantation by all three transplant centres in the 
Netherlands as well as by all other centres within the Eurotransplant region were included in 
this study. Five of the six livers were from DCD donors. The primary reasons for rejecting 
these livers for transplantation were; DCD livers from donors older than 60 years of age, 
 30% steatosis and uncontrolled cardiac arrest. Details on liver procurement, back-table 
and NMP procedures performed on these livers have been reported previously4. Livers were 
used for research purposes only, and were not intended to be transplanted following NMP. 
However, this research project has provided us important knowledge and insight in the ex-
situ perfusion of livers using a blood product free perfusion fluid, which enabled us to start a 
clinical trial recently (www.trialregister.nl; #NTR5972)   
The composition of the perfusion solution was described in detail previously4. In short, the 
livers were perfused with a 2202 ml heparinized solution containing Gelofusine, albumin, 
saline and the red blood cell substitute HBOC-201 (Hemopure®, HbO2 Therapeutics LCC. 
Souderton, PA, USA). Six plasma-based reference solutions using separate batches of fresh 
frozen plasma (FFP) provided to us by the blood bank were made in order to estimate the 
physiological relevance of the quantities of proteins generated in the plasma-free NMP 
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identical to the plasma-free perfusion solution. These six different batches were used in 
order to establish a reference interval.  
Concentrations of hemostatic proteins were analysed by enzyme-linked immunosorbent 
assays (ELISA), as the presence of heparin within the solutions prohibited meaningful 
quantification of these analytes using clot-based assays. 
Prothrombin was quantified using the Human Prothrombin total antigen assay ELISA kit 
(Molecular innovations, Inc, Novi, MI, USA). Perfusate levels of FVII, FV, FX, plasminogen, 
and protein C were quantified using ELISA kits from Abcam (Cambridge, UK). Antithrombin 
levels were quantified using the Antithrombin Human-Serpin duoset ELISA (R&D systems; 
Bio-Techne, Oxon, UK), and tissue plasminogen activator (tPA) levels using the ZYMUTEST 
TPA-AG (Brenntag, Dordrecht, the Netherlands), respectively. All ELISAs were performed 
according to manufacturer’s instructions. Von Willebrand factor (VWF) and fibrinogen 
antigen levels were determined with in-house ELISAs using commercially available 
polyclonal antibodies. (DAKO, Glostrup, Denmark).  
The increase in hemostatic protein production during NMP is expressed in percentages. The 
median concentration for each protein at the end of NMP in the plasma-free perfusate is 
expressed as percentage of the median concentration of the same protein in the plasma-
based reference solution. Correlation analysis was performed using SPSS version 23 for 
Windows (SPSS Inc., Chicago, Ill, USA). 
 
Results and Discussion 
Five of the six livers were from donation after circulatory death donors. The primary reasons 
for rejecting these livers for transplantation, donor demographics and the procedural 
variables of the six donor livers that underwent end-ischemic NMP have been described 
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No hemostatic proteins were detectable in the plasma-free perfusion fluid samples prior to 
connection of the livers to the NMP device. During NMP, gradual increases in perfusate 
levels of all the proteins measured were observed in all livers (Figure 1 A-J). Perfusate levels 
of procoagulant factors II, V, VII,  X, and fibrinogen exhibited a gradual steady increase 
reaching levels of up to 10%, 9%, 59%, 9% and 31% of the plasma-based reference 
solution, respectively (Supplementary Table 1). Substantial amounts of VWF were released 
by endothelial cells, reaching 76% of levels seen in the plasma-based reference solution. 
Levels of the anticoagulant proteins antithrombin III and protein C increased over time, with 
perfusate levels of protein C exceeding the levels in the plasma-based reference solution in 
some livers. Plasminogen gradually increased over time during NMP, amounting to close to 
20% of normal plasma levels at the end of NMP. Perfusate levels of tPA peaked at 30 
minutes and remained higher than tPA levels in the plasma-based reference solution. 
Interestingly, hemostatic protein production in the one DBD liver graft was not much different 
from the five DCD livers.  
For most of the hemostatic proteins, we observed considerable variations in increase in 
concentrations in the perfusion fluid among the six livers (Figure 1). To assess whether 
these variations could be explained by variations in the recovery of hepatocellular function 
during NMP, we correlated hepatocyte-derived hemostatic proteins concentrations with 
markers of hepatic function, such as bile production and lactate concentration in perfusate. 
Indeed, most hemostatic protein concentrations in the perfusion fluid correlated well with bile 
production at the corresponding time points (Figure 2). Similar significant correlations were 
found between hemostatic proteins and lactate concentrations (Supplementary Figure 1). 
These results demonstrate that during 6 hours of ex-situ NMP, isolated donor livers perfused 
with a plasma-free solution are able to generate substantial amounts of hemostatic proteins. 
The production of procoagulant proteins ranged between 9-57% of the levels measured in 
the plasma-based reference solution. Anticoagulant and fibrinolytic protein levels amounted 
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respectively. In addition, appreciable amounts of the endothelial-derived proteins, VWF, and 
tPA released into the perfusate indicate that besides adequate hepatocyte synthetic activity, 
the secretory function of sinusoidal endothelium is also maintained during NMP.  
To prevent coagulation activation and subsequent clot formation within the perfusion circuit 
and perhaps more importantly, in the liver itself, an anticoagulant agent is typically added to 
the perfusion solution during NMP. To date, anticoagulation management by most groups 
involves the use of heparin. Current NMP anticoagulation protocols in literature describe the 
addition of 10,000 to 25,000 units of heparin to the perfusion fluid during priming of the 
device. In some cases, additional boluses or continuous infusion are provided throughout 
NMP. Even though heparin is added to the machine perfusion fluid, heparin will only function 
as an anticoagulant in the presence of antithrombin. In this study, the concentrations of the 
procoagulant proteins (II, V and X) were generally lower compared to the anticoagulant and 
fibrinolytic proteins. Together with the profound production of tPA, this may indicate a 
favourable anticoagulant and profibrinolytic environment, at least in the first 6 hours of NMP. 
Additionally, antithrombin is generated in appreciable quantities and as the production of 
hemostatic proteins favours the anticoagulants, it is likely that heparin anticoagulation during 
plasma-free perfusate NMP is effective. Nevertheless, with production of all procoagulant 
proteins starting immediately after initiation of NMP, we postulate that more direct 
anticoagulants such as direct thrombin-inhibitors such as, Bivalirudin which, in contrast to 
other direct thrombin-inhibitors such as Dabigatran, does not require metabolic activation by 
the liver, may be more effective in the initial phase of NMP because such anticoagulants are 
antithrombin-independent.  
Although limited by a small sample size, inclusion of only a single DBD liver and a relatively 
short perfusion period, this is to our knowledge, the first study to demonstrate the capability 
of donor livers to produce substantial amounts of hemostatic proteins during NMP using a 
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 Despite the liver being responsible for the synthesis of these hemostatic proteins, we have 
previously elucidated that plasma levels of hemostatic proteins are not controlled by the 
liver5. Hormonal systems, extra-hepatic sensors and clearance of these proteins were 
proposed as possible mechanisms responsible for the regulation of the plasma levels of 
hemostatic proteins. Given the absence of these influences during ex-situ NMP of an 
isolated liver, it is likely that the generation of these proteins will proceed throughout NMP. 
Particularly for studies where donor livers are perfused for extended periods of time (10+ 
hours), one can speculate that this could potentially lead to the generation of a perfusion 
solution with plasma-like or even supra-physiological concentrations of these proteins 
towards the end of NMP. Therefore, future research is required to further investigate whether 
current anticoagulant protocols using heparin are sufficient to prevent coagulation both in the 
very early and late phases of prolonged NMP.   
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LEGENDS TO THE FIGURES 
Figure 1. Increases in concentrations of pro-coagulant, anti-coagulant and fibrinolytic 
proteins in 6 human donor livers during 6 hours of normothermic machine perfusion 
(NMP) using a plasma-free solution. Panel A; Factor II. Panel B; Factor V. Panel C; Factor 
VII. Panel D; Factor X. Panel E; Fibrinogen. Panel F; Von Willebrand factor (VWF). Panel G; 
Protein C. Panel H; Antithrombin III. Panel I; Plasminogen. Panel J; Tissue-type 
plasminogen activator (tPA) 
Figure 2. Correlations between production of hepatocyte-derived hemostatic proteins 
and total bile production during 6 hours of normothermic machine perfusion (NMP) of 
human donor livers using a plasma-free solution. Panel A; Factor II. Panel B; Factor V. 
Panel C; Factor VII. Panel D; Factor X Panel E; Fibrinogen. Panel F; Protein C. Panel G; 
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